SCHEMBL802992

SCHEMBL802992

COc1ccc(CCNC(=O)/C=C/c2ccc(O)cc2)cc1OC

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.83
LMNA P02545 2/20 0.76
ALDH1A1 P00352 2/20 0.75
KDM4E B2RXH2 1/20 0.75
PKM P14618 1/20 0.75
HPGD P15428 1/20 0.71
HTT P42858 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.70
CNR2 P34972 2/20 0.69
ACHE P22303 2/20 0.68
BCHE P06276 1/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
OPRM1 P35372 1/20 0.68
OPRD1 P41143 1/20 0.68
TYR P14679 1/20 0.67
MAOA P21397 1/20 0.64
MAOB P27338 1/20 0.64
MMP1 P03956 1/20 0.62
MMP2 P08253 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28994634 0.93 CNR2 (0.79) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL17956818 0.93 CNR2 (0.79) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL17956817 0.93 CNR2 (0.79) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL30354371 0.93 CNR2 (0.79) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL802998 0.92 ACHE (0.79) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL1917252 0.91 MAPT (0.84) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL31286546 0.91 MAPT (0.84) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL1917292 0.91 MAPT (0.84) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL32679235 0.91 MAPT (0.84) MAPTLMNAALDH1A1KDM4EPKM
SCHEMBL4812487 0.91 MAPT (0.84) MAPTLMNAALDH1A1KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295624-B2 Amide derivative and whitening agent AJINOMOTO CO., INC. (JP) 2016-03-29 US disclosed
EP-2412701-B1 NOVEL AMIDE DERIVATIVE AND SKIN WHITENING AGENT AJINOMOTO KK (JP) 2015-08-12 EP disclosed
US-20140255327-A1 NOVEL AMIDE DERIVATIVE AND WHITENING AGENT AJINOMOTO CO. INC. (JP) 2014-09-11 US disclosed
US-20120070395-A1 NOVEL AMIDE DERIVATIVE AND WHITENING AGENT AJINOMOTO CO. INC (JP) 2012-03-22 US disclosed
EP-2412701-A1 NOVEL AMIDE DERIVATIVE AND SKIN WHITENING AGENT Ajinomoto Co., Inc. (JP) 2012-02-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140255327-A1 NOVEL AMIDE DERIVATIVE AND WHITENING AGENT CUTA, NAT1, TYR MAPT 1419/4885LMNA 2148/4885ALDH1A1 163/4885
US-20120070395-A1 NOVEL AMIDE DERIVATIVE AND WHITENING AGENT CUTA, NAT1, TYR MAPT 1419/4885LMNA 2148/4885ALDH1A1 163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.